Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06148402
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2023-11-03
Brief Title:
Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With UnresectableMetastatic Colorectal Cancer
Sponsor:
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University